Arkansas Times12h
Paper-ballot proponents largely unsuccessful in ballot access lawsuits
Supporters of the Arkansas Voter Integrity Initiative filed nine lawsuits and only won two, both of which could still be ...
TD Cowen Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...
Nucleic Acid Therapeutics CDMO Industry Outlook, 2024-2030 - Increasing Demand for One-Stop-Shop CDMOs and Growing FDIs in Nucleic Acid Therapeutics
The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ...
STAT19h
Sarepta’s gene therapy is fully approved, but its stock has tanked. Here’s why
Since the FDA cleared Sarepta Thereapeutics' gene therapy for nearly all people with Duchenne, its stock price has tanked.